Skip to content

Clinical trials

Completed Phase 3 Vulvar Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Phase: Phase 3 Status: Completed Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20072
20092
20101
20112
20172
20181
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC6
Gynecologic Oncology Group3
Alliance for Clinical Trials in Oncology2
Shanghai Bovax Biotechnology Co., Ltd.2
INSYS Therapeutics Inc1
Institut Claudius Regaud1
Institut de Cancérologie de Lorraine1
University Magna Graecia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms17
Uterine Cervical Neoplasms12
Vaginal Neoplasms11
Condylomata Acuminata7
Papillomavirus Infections6
Endometrial Neoplasms4
Breast Neoplasms3
Fallopian Tube Neoplasms3
Anus Neoplasms2
Carcinoma, Ovarian Epithelial2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.